Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Interferon alfa may interfere with the growth of cancer cells.
Hyperthermia therapy kills tumor cells by heating them to several degrees above body
temperature. Combining hyperthermia with chemotherapy and interferon alfa may kill more tumor
cells.
PURPOSE: This phase I/II trial is studying the side effects of cisplatin, gemcitabine,
interferon alfa, and whole-body hyperthermia and how well they work in treating patients with
metastatic, recurrent, or refractory cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston